LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Deep postnatal phenotyping of a new mouse model of nonketotic hyperglycinemia.

    Swanson, Michael A / Jiang, Hua / Busquet, Nicolas / Carlsen, Jessica / Brindley, Connie / Benke, Tim A / Van Hove, Roxanne A / Friederich, Marisa W / MacLean, Kenneth N / Mesches, Michael H / Van Hove, Johan L K

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Nonketotic hyperglycinemia due to deficient glycine cleavage enzyme activity causes a severe neonatal epileptic encephalopathy. Current therapies based on mitigating glycine excess have only limited impact. An animal model with postnatal phenotyping is ... ...

    Abstract Nonketotic hyperglycinemia due to deficient glycine cleavage enzyme activity causes a severe neonatal epileptic encephalopathy. Current therapies based on mitigating glycine excess have only limited impact. An animal model with postnatal phenotyping is needed to explore new therapeutic approaches. We developed a
    Take home message: A mouse model of nonketotic hyperglycinemia is described that shows postnatal abnormalities in glycine levels, neural tube defects, body weight, electroencephalographic recordings, and in activity in young mice making it amenable for the evaluation of novel treatment interventions.
    Author contributions: Study concept and design: JVH, MHM, NB, KNMAnimal study data: MAS, HJ, NB, MHM, JC, CBBiochemical and genetic studies: MAS, RAVH, MWFStatistical analysis: NB, JVHFirst draft writing: JVH, NB, MHMCritical rewriting: MAS, NB, MHM, TAB, JC, MWF, KNM, JVHFinal responsibility, guarantor, and communicating author: JVH.
    Competing interest statement: The University of Colorado (JVH, MS, KNM, HJ) has the intention to file Intellectual property protection for certain biochemical treatments of NKH. Otherwise, the authors have stated that they had no interests that might be perceived as posing a conflict or bias to this subject matter.
    Funding support: Financial support is acknowledged form the NKH Crusaders, Brodyn's Friends, Nora Jane Almany Foundation, the Dickens Family Foundation, the Lucas John Foundation, Les Petits Bourdons, Joseph's Fund, the Barnett Family, Maud & Vic Foundation, Lucy's BEElievers fund, Hope for NKH, Madi's Mission NKH fund, and from Dr. and Ms. Shaw, and the University of Colorado Foundation NKH research fund. The study was supported by a grant (CNS-X-19-103) from the University of Colorado School of Medicine and the Colorado Clinical Translational Science Institute, which is supported by NIH/NCATS Colorado CTSA Grant Number UL1 TR002535. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. All funding sources had no role in the design or execution of the study, the interpretation of data, or the writing of the study.
    Ethics approval on laboratory animal studies: Mouse studies were carried out with approval from the Institutional Animal Care and Use Committee of the University of Colorado Anschutz Medical Campus (IACUC# 00413).
    Data sharing statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.03.26.586818
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.

    Van Hove, Johan L K / Friederich, Marisa W / Strode, Dana K / Van Hove, Roxanne A / Miller, Kristen R / Sharma, Rohit / Shah, Hardik / Estrella, Jane / Gabel, Linda / Horslen, Simon / Kohli, Rohit / Lovell, Mark A / Miethke, Alexander G / Molleston, Jean P / Romero, Rene / Squires, James E / Alonso, Estella M / Guthery, Stephen L / Kamath, Binita M /
    Loomes, Kathleen M / Rosenthal, Philip / Mysore, Krupa R / Cavallo, Laurel A / Valentino, Pamela L / Magee, John C / Sundaram, Shikha S / Sokol, Ronald J

    Hepatology communications

    2024  Volume 8, Issue 1

    Abstract: Background: Mitochondrial hepatopathies (MHs) are primary mitochondrial genetic disorders that can present as childhood liver disease. No recognized biomarkers discriminate MH from other childhood liver diseases. The protein biomarkers growth ... ...

    Abstract Background: Mitochondrial hepatopathies (MHs) are primary mitochondrial genetic disorders that can present as childhood liver disease. No recognized biomarkers discriminate MH from other childhood liver diseases. The protein biomarkers growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21) differentiate mitochondrial myopathies from other myopathies. We evaluated these biomarkers to determine if they discriminate MH from other liver diseases in children.
    Methods: Serum biomarkers were measured in 36 children with MH (17 had a genetic diagnosis); 38 each with biliary atresia, α1-antitrypsin deficiency, and Alagille syndrome; 20 with NASH; and 186 controls.
    Results: GDF15 levels compared to controls were mildly elevated in patients with α1-antitrypsin deficiency, Alagille syndrome, and biliary atresia-young subgroup, but markedly elevated in MH (p<0.001). FGF21 levels were mildly elevated in NASH and markedly elevated in MH (p<0.001). Both biomarkers were higher in patients with MH with a known genetic cause but were similar in acute and chronic presentations. Both markers had a strong performance to identify MH with a molecular diagnosis with the AUC for GDF15 0.93±0.04 and for FGF21 0.90±0.06. Simultaneous elevation of both markers >98th percentile of controls identified genetically confirmed MH with a sensitivity of 88% and specificity of 96%. In MH, independent predictors of survival without requiring liver transplantation were international normalized ratio and either GDF15 or FGF21 levels, with levels <2000 ng/L predicting survival without liver transplantation (p<0.01).
    Conclusions: GDF15 and FGF21 are significantly higher in children with MH compared to other childhood liver diseases and controls and, when combined, were predictive of MH and had prognostic implications.
    MeSH term(s) Child ; Humans ; Alagille Syndrome/diagnosis ; Biliary Atresia/diagnosis ; Biomarkers ; Growth Differentiation Factor 15/blood ; Growth Differentiation Factor 15/chemistry ; Non-alcoholic Fatty Liver Disease ; Mitochondrial Diseases/diagnosis
    Chemical Substances Biomarkers ; fibroblast growth factor 21 ; GDF15 protein, human ; Growth Differentiation Factor 15
    Language English
    Publishing date 2024-01-05
    Publishing country United States
    Document type Journal Article
    ISSN 2471-254X
    ISSN (online) 2471-254X
    DOI 10.1097/HC9.0000000000000361
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pathogenic variants in NUBPL result in failure to assemble the matrix arm of complex I and cause a complex leukoencephalopathy with thalamic involvement.

    Friederich, Marisa W / Perez, Francisco A / Knight, Kaz M / Van Hove, Roxanne A / Yang, Samuel P / Saneto, Russell P / Van Hove, Johan L K

    Molecular genetics and metabolism

    2019  Volume 129, Issue 3, Page(s) 236–242

    Abstract: Disorders of the white matter are genetically very heterogeneous including several genes involved in mitochondrial bioenergetics. Diagnosis of the underlying cause is aided by pattern recognition on neuroimaging and by next-generation sequencing. ... ...

    Abstract Disorders of the white matter are genetically very heterogeneous including several genes involved in mitochondrial bioenergetics. Diagnosis of the underlying cause is aided by pattern recognition on neuroimaging and by next-generation sequencing. Recently, genetic changes in the complex I assembly factor NUBPL have been characterized by a consistent recognizable pattern of leukoencephalopathy affecting deep white matter including the corpus callosum and cerebellum. Here, we report twin boys with biallelic variants in NUBPL, an unreported c.351 G > A; p.(Met117Ile) and a previously reported pathological variant c. 693 + 1 G > A. Brain magnetic resonance imaging showed abnormal T2 hyperintense signal involving the periventricular white matter, external capsule, corpus callosum, and, prominently, the bilateral thalami. The neuroimaging pattern evolved over 18 months with marked diffuse white matter signal abnormality, volume loss, and new areas of signal abnormality in the cerebellar folia and vermis. Magnetic resonance spectroscopy showed elevated lactate. Functional studies in cultured fibroblasts confirmed pathogenicity of the genetic variants. Complex I activity of the respiratory chain was deficient spectrophotometrically and on blue native gel with in-gel activity staining. There was absent assembly and loss of proteins of the matrix arm of complex I when traced with an antibody to NDUFS2, and incomplete assembly of the membrane arm when traced with an NDUFB6 antibody. There was decreased NUBPL protein on Western blot in patient fibroblasts compared to controls. Compromised NUBPL activity impairs assembly of the matrix arm of complex I and produces a severe, rapidly-progressive leukoencephalopathy with thalamic involvement on MRI, further expanding the neuroimaging phenotype.
    MeSH term(s) Cell Line ; Corpus Callosum/diagnostic imaging ; Corpus Callosum/pathology ; Diseases in Twins/diagnostic imaging ; Diseases in Twins/genetics ; Diseases in Twins/metabolism ; Diseases in Twins/physiopathology ; Electron Transport Complex I/deficiency ; Electron Transport Complex I/genetics ; Electron Transport Complex I/metabolism ; External Capsule/diagnostic imaging ; External Capsule/pathology ; Eye/physiopathology ; Fibroblasts/metabolism ; Humans ; Infant ; Lactic Acid/metabolism ; Leukoencephalopathies/diagnostic imaging ; Leukoencephalopathies/genetics ; Leukoencephalopathies/metabolism ; Leukoencephalopathies/physiopathology ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Male ; Mitochondria/genetics ; Mitochondria/metabolism ; Mitochondrial Proteins/genetics ; Mitochondrial Proteins/metabolism ; Mutation ; NADH Dehydrogenase/metabolism ; Thalamus/diagnostic imaging ; Twins, Monozygotic/genetics ; White Matter/diagnostic imaging ; White Matter/pathology ; Exome Sequencing
    Chemical Substances Mitochondrial Proteins ; NUBPL protein, human ; Lactic Acid (33X04XA5AT) ; NADH Dehydrogenase (EC 1.6.99.3) ; Electron Transport Complex I (EC 7.1.1.2) ; NDUFB6 protein, human (EC 7.1.1.2) ; NDUFS2 protein, human (EC 7.1.1.2)
    Language English
    Publishing date 2019-12-30
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1418518-0
    ISSN 1096-7206 ; 1096-7192
    ISSN (online) 1096-7206
    ISSN 1096-7192
    DOI 10.1016/j.ymgme.2019.12.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The complete mitochondrial genomes of five lichenized fungi in the genus

    Funk, Erik R / Adams, Alexander N / Spotten, Sarah M / Van Hove, Roxanne A / Whittington, Kristina T / Keepers, Kyle G / Pogoda, Cloe S / Lendemer, James C / Tripp, Erin A / Kane, Nolan C

    Mitochondrial DNA. Part B, Resources

    2018  Volume 3, Issue 1, Page(s) 305–308

    Abstract: Known colloquially as 'Old Man's Beard', ...

    Abstract Known colloquially as 'Old Man's Beard',
    Language English
    Publishing date 2018-02-28
    Publishing country England
    Document type Journal Article
    ISSN 2380-2359
    ISSN (online) 2380-2359
    DOI 10.1080/23802359.2018.1445485
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top